Abstract: Nucleic acid expression control sequence cassettes and vectors containing the same are provided for use in making abundant quantities of recombinant polypeptides of interest. The modified transcriptional control sequences, which include a T5 promoter sequence, are highly stable and can be used in a variety of vectors, such as plasmids.

Abstract: The present disclosure relates to compositions and methods for treating or preventing coronavirus infections. For example, compositions are provided that comprise a coronavirus S protein or N protein, fragment, or variant thereof, capable of eliciting a protective humoral and/or cell-mediated immune response, which compositions are useful for treating or preventing infection by coronavirus, such as the causative agent of SARS. Also, coronavirus S protein and N protein immunogen compositions are provided that include an adjuvant, such as Proteosome or Protollin, which may be used for treating or preventing infection caused by a coronavirus, such as a SARS coronavirus.

Abstract: Nucleic acid expression control sequence cassettes and vectors containing the same are provided for use in making abundant quantities of recombinant polypeptides of interest. The modified transcriptional control sequences, which include a T5 promoter sequence, are highly stable and can be used in a variety of vectors, such as plasmids.

Abstract: A skin condition relieving medication, which can be directly applied onto a skin condition prone area of a user, is provided for preventing infection and reducing inflammation and swelling, while allowing air to reach the skin condition prone area in order to dry the skin condition and eventually healing the skin condition, wherein the skin condition relieving medication includes a predetermined amount of primary herb mixture including one or more herbs chosen from forsythia, frankincense, myrrh, cuttlefish bone, honeysuckle, turmeric and garden angelica, provided for the treating of the skin conditions, a predetermined amount of catalyst including vitamin E, and a predetermined amount of binding agent, which most suitably is Vaseline containing the primary herb mixture and the catalyst, and binding the primary herb mixture to the skin condition prone area of the user.